Diagnostic Test Performance - USMLE Step 1

1. What is the positive likelihood ratio (LR+) for this serum marker?
   Answer: 15 The positive likelihood ratio (LR+) is calculated as sensitivity / (1 - specificity). In this case, LR+ = 0.75 / (1 - 0.95) = 0.75 / 0.05 = 15. This indicates that a positive test result makes it 15 times more likely that the patient has the disease.
2. What is the negative predictive value (NPV) of this test in this population?
   Answer: 98% First, construct a 2x2 table. With a prevalence of 10% in a population of 1000, 100 individuals have the disease and 900 do not. False Negatives (FN) = 100 (1 - sensitivity) = 100 0.20 = 20. True Negatives (TN) = 900 specificity = 900 0.90 = 810. NPV = TN / (TN + FN) = 810 / (810 + 20) = 810 / 830 ≈ 98%.
3. Compared to its use in the high-risk population, what is the most likely effect on the test's positive predictive value (PPV) when used in the low-risk population?
   Answer: PPV will decrease. The positive predictive value (PPV) is highly dependent on the prevalence of the disease in the population being tested. As the prevalence of a disease decreases, the PPV of a test also decreases. Therefore, using the test in a low-prevalence population will result in a lower PPV.
4. To achieve this goal, a test with which of the following characteristics would be most useful?
   Answer: High sensitivity A highly sensitive test is best for ruling out a disease. If a test has high sensitivity, it will correctly identify most individuals with the disease, meaning a negative result is very likely to be a true negative. This is often remembered by the mnemonic SN-N-OUT (Sensitive test, Negative result, rules OUT disease).
5. Compared to using the first screening test alone, what is the primary effect of this two-step (serial) testing strategy on the overall diagnostic characteristics?
   Answer: Increased net specificity This describes serial testing, where a positive on test 1 is followed by test 2, and the diagnosis is made only if both are positive. This approach increases the overall specificity of the diagnostic process because it reduces the number of false positives that would have occurred with the sensitive screening test alone. However, it decreases the overall sensitivity.
6. What is the main advantage of this parallel testing strategy?
   Answer: It increases the overall sensitivity. This describes parallel testing, where a patient is considered positive if at least one of several tests is positive. This strategy maximizes the probability of detecting the disease, thereby increasing the overall sensitivity of the diagnostic process. The trade-off is a decrease in overall specificity, as there are more opportunities for a false-positive result.
7. The physician will answer the patient's question by providing which of the following values?
   Answer: Negative predictive value The negative predictive value (NPV) is the probability that a patient with a negative test result is truly free of the disease. The patient's question directly corresponds to the definition of NPV.
8. What is the sensitivity of this new ELISA for detecting the viral infection?
   Answer: 90% Sensitivity is calculated as True Positives / (True Positives + False Negatives). Here, True Positives (TP) = 180. The total number of infected patients is 200, so False Negatives (FN) = 200 - 180 = 20. Sensitivity = 180 / (180 + 20) = 180 / 200 = 90%.
9. Which of the following would be the most likely consequence of lowering the diagnostic cut-off value?
   Answer: Sensitivity will increase and specificity will decrease. There is an inverse relationship between sensitivity and specificity when a diagnostic cut-off point is changed. Lowering the cut-off value makes it easier to get a positive result. This will correctly identify more individuals with the disease (increasing sensitivity), but it will also incorrectly classify more healthy individuals as positive (increasing false positives, thus decreasing specificity).
10. The patient's question is asking for which of the following statistical measures?
    Answer: Positive predictive value The positive predictive value (PPV) is the probability that a patient with a positive test result truly has the disease. The patient's question directly corresponds to the definition of PPV.
11. How will the negative predictive value (NPV) of the test in Group A (low prevalence) compare to the NPV in Group B (high prevalence)?
    Answer: NPV will be higher in Group A. The negative predictive value (NPV) is inversely related to the prevalence of the disease in the population. As the prevalence of a disease decreases, the NPV of a test increases. Therefore, the NPV will be higher in the low-prevalence Group A compared to the high-prevalence Group B.
12. What is the negative likelihood ratio (LR-) of the D-dimer test for PE?
    Answer: 0.1 The negative likelihood ratio (LR-) is calculated as (1 - sensitivity) / specificity. In this case, LR- = (1 - 0.95) / 0.50 = 0.05 / 0.50 = 0.1. An LR- of 0.1 is considered very useful for ruling out a disease, as a negative result substantially decreases the odds of the disease being present.
13. What is the positive predictive value (PPV) of this test in this population?
    Answer: 47% First, construct a 2x2 table. With a prevalence of 10% in a population of 1000, 100 individuals have the disease and 900 do not. True Positives (TP) = 100 sensitivity = 100 0.80 = 80. False Positives (FP) = 900 (1 - specificity) = 900 0.10 = 90. PPV = TP / (TP + FP) = 80 / (80 + 90) = 80 / 170 ≈ 47%.
14. This study is primarily designed to measure which of the following test characteristics?
    Answer: Specificity Specificity is the ability of a test to correctly identify individuals who do not have the disease (true negative rate). The study aims to measure the proportion of healthy individuals who are correctly identified as negative, which is the definition of specificity.
15. How does this negative test result affect the likelihood of the patient having SLE?
    Answer: It decreases the odds of disease by 80%. The negative likelihood ratio (LR-) indicates how much the odds of disease decrease with a negative test result. An LR- of 0.2 means the post-test odds are 0.2 times the pre-test odds (Post-test odds = Pre-test odds * 0.2). This represents a 1 - 0.2 = 0.8, or an 80% decrease in the odds of having the disease.
16. Which of the following test characteristics is expected to remain constant across both the specialty clinic and the primary care setting?
    Answer: Specificity Sensitivity and specificity are intrinsic properties of a diagnostic test that do not change with the prevalence of the disease in the population being tested. In contrast, positive and negative predictive values are highly dependent on disease prevalence.
17. What is the specificity of the rapid diagnostic test?
    Answer: 90% Specificity is calculated as True Negatives / (True Negatives + False Positives). Here, True Negatives (TN) = 225. The total number of patients without the disease is 250, so False Positives (FP) = 250 - 225 = 25. Specificity = 225 / (225 + 25) = 225 / 250 = 90%.
18. Which of the following is the most accurate interpretation of this positive test result?
    Answer: The odds of the patient having the disease have increased by a factor of 5. The likelihood ratio is a measure of how much a test result changes the odds of having a disease. A positive likelihood ratio (LR+) of 5.0 means that a positive test result makes the odds of having the disease 5 times greater than they were before the test. It is calculated as Post-test odds = Pre-test odds * LR+.
19. A confirmatory test with which of the following characteristics would be most appropriate in this situation?
    Answer: High specificity A highly specific test is best for confirming a diagnosis. If a test has high specificity, it has a low false-positive rate. A positive result from a highly specific test provides strong evidence that the disease is present. This is often remembered by the mnemonic SP-P-IN (Specific test, Positive result, rules IN disease).
20. Which of the following test characteristics is being evaluated?
    Answer: Sensitivity Sensitivity is the ability of a test to correctly identify individuals who have the disease (true positive rate). The question describes assessing the test's performance in a population of known infected individuals.

Start this quiz